Why can CTLA4Ig-primed sequential DLI improve chronic GvHD and RFS after allo-HSCT? GvHD Hub 4:56 4 years ago 161 Далее Скачать
DLI following haploHCT PTCy relapse VJHemOnc – Video Journal of Hematology & HemOnc 2:33 4 years ago 481 Далее Скачать
Post-allogeneic transplant interventions in ALL VJHemOnc – Video Journal of Hematology & HemOnc 4:16 3 years ago 245 Далее Скачать
Practical considerations for DLI after haploidentical SCT VJHemOnc – Video Journal of Hematology & HemOnc 2:21 1 year ago 79 Далее Скачать
Treosulfan + fludarabine vs busulfan + fludarabine in active AML post-alloHSCT VJHemOnc – Video Journal of Hematology & HemOnc 3:34 2 years ago 476 Далее Скачать
Anti-CTLA-4 Unleashing the Power of T Cells in Combination Immunotherapy Assay Genie 15:02 1 month ago 36 Далее Скачать
Post-transplant maintenance strategies in AML VJHemOnc – Video Journal of Hematology & HemOnc 2:21 3 years ago 179 Далее Скачать
The importance of genomic testing when making treatment decisions in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:36 2 years ago 143 Далее Скачать
Phase Ib/II trial of siremadlin alone or in combination with DLI in high-risk AML post-alloSCT VJHemOnc – Video Journal of Hematology & HemOnc 2:15 1 year ago 121 Далее Скачать
Panobinostat and donor lymphocyte infusions in patients with high-risk AML and MDS VJHemOnc – Video Journal of Hematology & HemOnc 2:02 8 years ago 659 Далее Скачать
The importance of diagnostic testing in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:39 8 years ago 294 Далее Скачать
Small molecule inhibitors for CLL: which to use, sequencing, switching and combinations VJHemOnc – Video Journal of Hematology & HemOnc 3:29 6 years ago 235 Далее Скачать
Sequencing of therapies to improve outcomes of CLL patients VJHemOnc – Video Journal of Hematology & HemOnc 1:09 1 year ago 126 Далее Скачать
The importance of treatment sequencing in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:29 2 years ago 306 Далее Скачать
IL3-zetakine coupled to a CD33 costimulatory receptor as a dual-targeting CAR approach in AML VJHemOnc – Video Journal of Hematology & HemOnc 1:27 1 year ago 44 Далее Скачать
What is the optimal timepoint for post-transplant MRD assessment? AML Hub 2:36 3 years ago 58 Далее Скачать
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting VJHemOnc – Video Journal of Hematology & HemOnc 2:05 7 months ago 234 Далее Скачать
